📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
NCLT Approves Hindustan Foods' Scheme of Arrangement and Nashik Business Demerger
The NCLT Mumbai has sanctioned the Scheme of Arrangement involving the demerger of the Nashik-based contract manufacturing business from Avalon Cosmetics into Hindustan Foods. Additionally, Vanity Case India, which holds a 40.55% stake in the company, will be amalgamated into Hindustan Foods to simplify the promoter holding structure. The demerger includes approximately 16 acres of land in Nashik, where an ice cream manufacturing facility is already being planned. This move aims to consolidate FMCG operations and improve operational efficiencies through pooled resources.
Key Highlights
Demerger swap ratio set at 19 equity shares of HFL (FV ₹2) for every 100 shares held in Avalon Cosmetics (FV ₹10)
Amalgamation of Vanity Case India (VCIPL) involves issuing 4,64,58,145 shares to its shareholders, mirroring its current 40.55% stake
Acquisition of a 16-acre manufacturing site in Nashik with over 1 lakh sq. ft. of built-up area for expansion
The scheme enables HFL to diversify into ice cream manufacturing at the newly acquired Nashik premises
Simplifies promoter structure by eliminating layers, with Kothari and Dempo groups to hold HFL shares directly
💼 Action for Investors
Investors should view this as a positive consolidation move that adds tangible assets and simplifies the corporate structure. Monitor the effective date of the scheme and the progress of the new ice cream manufacturing facility as key growth drivers.
Hindustan Foods Q3 PAT Rises 26% to ₹36 Cr; Guides FY27 PAT at ₹200-220 Cr
Hindustan Foods reported its highest-ever quarterly EBITDA of ₹93 crores in Q3 FY26, with PAT growing 26% YoY to ₹36 crores despite a one-time labor code provision. The company successfully executed a massive ₹750 crore capex program in FY26, representing 60% of its opening gross block, to diversify into beverages, ice creams, and home care. Management issued a strong growth guidance for FY27, targeting a PAT of ₹200-220 crores as these new capacities ramp up. Financial discipline remains intact with an adjusted ROCE of 19% and a comfortable net debt-to-equity ratio of 0.77x.
Key Highlights
Achieved highest-ever quarterly EBITDA of ₹93 crores and PAT of ₹36 crores in Q3 FY26.
Completed cumulative capex of over ₹750 crores in FY26, adding 5 lakh square feet of manufacturing space.
Provided FY27 PAT guidance of ₹200-220 crores, representing approximately 1.4x growth over FY26 estimates.
Board approved a new ₹50 crore greenfield Home & Personal Care (HPC) project in Lucknow.
Maintained healthy financial metrics with adjusted ROCE at 19% and net debt-to-equity at 0.77x.
💼 Action for Investors
Investors should consider the stock favorably as the company transitions from a heavy investment phase to a high-growth phase with clear FY27 earnings visibility. Monitor the ramp-up of the new beverage and ice cream capacities starting Q4 FY26 for immediate performance cues.
Hindustan Foods Q3 PAT Rises 26% to ₹36 Cr; Projects FY27 PAT of ₹200-220 Cr
Hindustan Foods reported its highest-ever quarterly performance with Q3FY26 revenue reaching ₹1,000 crore, a 13% YoY increase. Net profit grew 26% YoY to ₹36 crore despite a one-time ₹3.5 crore provision for labor code changes. The company is in a peak investment phase, having deployed over ₹750 crore in capex during FY26, with most capacity expected to commission by March 2026. Management has provided strong forward guidance, targeting a PAT of ₹200-220 crore for FY27, driven by operating leverage and new capacity utilization.
Key Highlights
Highest-ever quarterly EBITDA of ₹93 crore and PAT of ₹36 crore recorded in Q3FY26.
9MFY26 PAT grew 30.6% YoY to ₹103.1 crore on revenue of ₹3,041 crore.
Aggressive capex of ₹750+ crore in FY26 represents 64% of the opening gross block.
Management guidance projects FY27 PAT at ₹200-220 crore, nearly doubling from FY25 levels.
Maintained balance sheet discipline with Net Debt-to-Equity at 0.77x and adjusted ROCE at 19.1%.
💼 Action for Investors
The company is successfully transitioning from a high-capex phase to a utilization-led growth phase, making it a strong play on the Indian FMCG outsourcing theme. Investors should monitor the timely commissioning of the Panipat and Baddi facilities in H1FY27 to validate the FY27 guidance.
HNDFDS Q3FY26 PAT Rises 26% to ₹36 Cr; Highest Ever Quarterly Performance
Hindustan Foods reported its highest-ever quarterly performance in Q3FY26, with revenue reaching ₹1,000 crore, a 13% YoY increase. Net profit (PAT) grew by 26% to ₹36 crore, despite a one-time ₹3.5 crore charge related to the new labour code. The company is in a peak investment phase, having undertaken ₹750 crore in capex for FY26, with most assets expected to be commissioned by March 2026. Management maintained its FY27 PAT guidance of ₹200–220 crore, supported by a healthy adjusted ROCE of 19%.
Key Highlights
Q3FY26 Total Income crossed the ₹1,000 crore mark, growing 13% YoY.
EBITDA for the quarter rose 18% to ₹93 crore, reflecting improved operating leverage.
Cumulative FY26 capex of ₹750 crore is nearing completion, with a new ₹50 crore HPC project signed for FY27.
Adjusted ROCE remains healthy at 19% after normalizing for ₹400 crore in underutilized or uncommissioned assets.
Reaffirmed FY27 PAT guidance of ₹200–220 crore, providing strong growth visibility for long-term investors.
💼 Action for Investors
Investors should view the consistent execution and capacity expansion positively as the company transitions from an investment phase to a utilization ramp-up phase. Monitor the commissioning of the ₹750 crore capex and its impact on margins in the upcoming quarters.
Hindustan Foods Q3 FY26 PAT Rises 25.8% YoY to ₹36.12 Cr; Revenue Up 13.5%
Hindustan Foods reported a steady performance for the quarter ended December 31, 2025, with consolidated revenue from operations growing 13.5% year-on-year to ₹998.24 crores. Despite an exceptional item of ₹3.50 crores, the net profit for the quarter increased by 25.8% to ₹36.12 crores compared to ₹28.70 crores in the same period last year. For the nine-month period, the company crossed the ₹3,000 crore revenue milestone, reaching ₹3,031.51 crores. The company continues to maintain its focus on the contract manufacturing segment, which remains its primary business driver.
Key Highlights
Consolidated Revenue from Operations grew 13.5% YoY to ₹998.24 crores in Q3 FY26.
Net Profit (PAT) increased by 25.8% YoY to ₹36.12 crores, up from ₹28.70 crores.
Nine-month (9M FY26) Revenue reached ₹3,031.51 crores, a 15.2% increase over 9M FY25.
Basic and Diluted EPS improved to ₹3.02 for the quarter compared to ₹2.44 in the previous year's corresponding quarter.
The company reported an exceptional item of ₹3.50 crores during the current quarter.
💼 Action for Investors
Investors should view the consistent double-digit growth in revenue and profit as a sign of strong execution in the contract manufacturing space. The stock remains a solid play on the FMCG outsourcing theme, though monitoring the impact of exceptional items is advised.